BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7751472)

  • 1. Expression of bcl-2 protein and Ki-67 nuclear proliferation antigen in benign and malignant cutaneous T-cell infiltrates.
    Dummer R; Michie SA; Kell D; Gould JW; Haeffner AC; Smoller BR; Warnke RA; Wood GS
    J Cutan Pathol; 1995 Feb; 22(1):11-7. PubMed ID: 7751472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of proliferation markers and cell cycle regulators in T cell lymphoproliferative skin disorders.
    Gambichler T; Bischoff S; Bechara FG; Altmeyer P; Kreuter A
    J Dermatol Sci; 2008 Feb; 49(2):125-32. PubMed ID: 17826963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoreactivity for bcl-2 protein in cutaneous lymphomas and lymphoid hyperplasias.
    Triscott JA; Ritter JH; Swanson PE; Wick MR
    J Cutan Pathol; 1995 Feb; 22(1):2-10. PubMed ID: 7751474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycosis fungoides: expression of C-myc p62 p53, bcl-2 and PCNA proteins and absence of association with Epstein-Barr virus.
    Kanavaros P; Ioannidou D; Tzardi M; Datseris G; Katsantonis J; Delidis G; Tosca A
    Pathol Res Pract; 1994 Sep; 190(8):767-74. PubMed ID: 7831152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proapoptotic and antiapoptotic markers in cutaneous T-cell lymphoma skin infiltrates and lymphomatoid papulosis.
    Nevala H; Karenko L; Vakeva L; Ranki A
    Br J Dermatol; 2001 Dec; 145(6):928-37. PubMed ID: 11899146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early diagnosis of mycosis fungoides and Sézary's syndrome by morphometric analysis of lymphoid cells in the skin.
    Meijer CJ; van der Loo EM; van Vloten WA; van der Velde EA; Scheffer E; Cornelisse CJ
    Cancer; 1980 Jun; 45(11):2864-71. PubMed ID: 6966534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of T-cell antigen losses in mycosis fungoides and CD30-positive cutaneous T-cell lymphoproliferations in a series of 153 patients.
    Wechsler J; Ingen-Housz-Oro S; Deschamps L; Brunet-Possenti F; Deschamps J; Delfau MH; Calderaro J; Ortonne N
    Pathology; 2022 Oct; 54(6):729-737. PubMed ID: 35577607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptotic and proliferating cells in cutaneous lymphoproliferative diseases.
    Kikuchi A; Nishikawa T
    Arch Dermatol; 1997 Jul; 133(7):829-33. PubMed ID: 9236520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of MCM-3 and MCM-7 in Primary Cutaneous T-cell Lymphomas.
    Jankowska-Konsur A; Kobierzycki C; Reich A; Grzegrzolka J; Maj J; Dziegiel P
    Anticancer Res; 2015 Nov; 35(11):6017-26. PubMed ID: 26504025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of SATB1, MTI/II and Ki-67 in Mycosis Fungoides.
    Jankowska-Konsur A; Kobierzycki C; Reich A; Grzegrzolka J; Bieniek A; Dziegiel P
    Anticancer Res; 2016 Jan; 36(1):189-97. PubMed ID: 26722043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The T-cell chemokine receptor CXCR3 is expressed highly in low-grade mycosis fungoides.
    Lu D; Duvic M; Medeiros LJ; Luthra R; Dorfman DM; Jones D
    Am J Clin Pathol; 2001 Mar; 115(3):413-21. PubMed ID: 11242798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TOX expression in different subtypes of cutaneous lymphoma.
    Morimura S; Sugaya M; Suga H; Miyagaki T; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    Arch Dermatol Res; 2014 Nov; 306(9):843-9. PubMed ID: 25216799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of inhibitory signaling receptor programmed death marker-1 (PD-1) in disease evolution from cutaneous lymphoid dyscrasias to mycosis fungoides and Sezary's syndrome.
    Nguyen GH; Olson LC; Magro CM
    Ann Diagn Pathol; 2017 Jun; 28():54-59. PubMed ID: 28648940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lymphomatoid papulosis].
    Dreno B
    Presse Med; 1995 Jun; 24(23):1084-7. PubMed ID: 7567810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoreactivity for bcl-2 protein in cutaneous lymphomas and lymphoid hyperplasias.
    Cerroni L; Kerl H
    J Cutan Pathol; 1995 Oct; 22(5):476-8. PubMed ID: 8594083
    [No Abstract]   [Full Text] [Related]  

  • 16. The expression of the Hodgkin's disease-associated antigen Ki-1 in cutaneous infiltrates.
    van der Putte SC; Toonstra J; van Wichen DF; van Unnik JA; van Vloten WA
    Acta Derm Venereol; 1988; 68(3):202-8. PubMed ID: 2455412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates.
    Magro CM; Dyrsen ME
    J Cutan Pathol; 2008 Nov; 35(11):1040-9. PubMed ID: 18681860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
    Bosisio FM; Cerroni L
    Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical expression of BCL-2 in melanomas and intradermal nevi.
    Saenz-Santamaría MC; Reed JA; McNutt NS; Shea CR
    J Cutan Pathol; 1994 Oct; 21(5):393-7. PubMed ID: 7868749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult pityriasis lichenoides-like mycosis fungoides: a clinical variant of mycosis fungoides.
    de Unamuno Bustos B; Ferriols AP; Sánchez RB; Rabasco AG; Vela CG; Piris MA; Alegre de Míquel V
    Int J Dermatol; 2014 Nov; 53(11):1331-8. PubMed ID: 24961281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.